Cellectis Correlations

CLLS Stock  USD 3.50  0.04  1.13%   
The current 90-days correlation between Cellectis SA and Alto Neuroscience is 0.32 (i.e., Weak diversification). The correlation of Cellectis is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Cellectis Correlation With Market

Good diversification

The correlation between Cellectis SA and DJI is -0.02 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Cellectis SA and DJI in the same portfolio, assuming nothing else is changed.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cellectis SA. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Moving together with Cellectis Stock

  0.64BCAX Bicara TherapeuticsPairCorr

Moving against Cellectis Stock

  0.73KRRO Frequency TherapeuticsPairCorr
  0.44QSI QuantumSiPairCorr
  0.37JUMP Leveljump Healthcare CorpPairCorr
  0.37EVGN EvogenePairCorr
  0.52RNAZ Transcode Therapeutics Upward RallyPairCorr
  0.43PROK ProKidney CorpPairCorr
  0.47CABA Cabaletta BioPairCorr
  0.42SMFNF Sumitomo Mitsui FinancialPairCorr
  0.41CVX Chevron CorpPairCorr

Related Correlations Analysis


Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

DBVTDRTS
MREOSLN
DBVTANRO
DRTSACIU
DRTSANRO
MREOLRMR
  

High negative correlations

SLNDRTS
MREODRTS
DBVTSLN
MREOACIU
AMRNANRO
MREODBVT

Risk-Adjusted Indicators

There is a big difference between Cellectis Stock performing well and Cellectis Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Cellectis' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
ANRO  4.17  0.11  0.02  0.13  6.72 
 7.77 
 30.37 
ACIU  3.60 (0.17) 0.00 (0.05) 0.00 
 7.01 
 26.05 
ALDX  3.66  0.16  0.03 (10.29) 4.48 
 6.27 
 42.93 
AMRN  2.29 (0.19) 0.00 (0.32) 0.00 
 4.89 
 21.26 
DRTS  4.08  0.76  0.18  0.23  3.94 
 10.48 
 28.89 
LRMR  3.39 (0.25) 0.00 (0.26) 0.00 
 6.96 
 20.14 
SLN  3.06 (0.63) 0.00 (1.85) 0.00 
 6.88 
 23.80 
DBVT  4.22  0.98  0.21 (0.84) 3.71 
 10.53 
 36.36 
MREO  6.54 (0.25) 0.00 (0.11) 0.00 
 16.33 
 101.95 
KRRO  5.13 (0.80) 0.00 (0.11) 0.00 
 10.98 
 83.21 

Cellectis Corporate Management

Dr MBAChief OfficerProfile
Steven DoaresNorth RaleighProfile
Valerie CrosPrincipal OfficerProfile
Philippe DuchateauChief Scientific OfficerProfile
Pascalyne WilsonDirector CommunicationsProfile
MBA MDChief OfficerProfile
Arthur StrilInterim OfficerProfile